Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Xingrong Plastic Surgery Hospital is a premier Grade 3 specialty medical institution located in Chongqing, China, focusing on plastic and reconstructive surgery. The hospital was established by Professor Li Shirong, a prominent figure in the Chinese Association of Plastics and Aesthetics, and is now a key asset within the Fosun Health portfolio. It offers a wide array of services ranging from complex organ reconstruction and trauma repair to popular cosmetic procedures like rhinoplasty and skin rejuvenation. The facility serves as a major regional hub for clinical excellence, medical education, and the application of advanced aesthetic technologies. As a high-level specialty hospital, it integrates surgical expertise with comprehensive post-operative care and dermatological services. The institution is recognized for its state-of-the-art infrastructure and its role in advancing medical aesthetic standards in Southwest China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Xingrong Plastic Surgery Hospital.